The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsumoto, M.
Right arrow Articles by Aderem, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsumoto, M.
Right arrow Articles by Aderem, A.
The Journal of Immunology, 2004, 172: 7377-7384.
Copyright © 2004 by The American Association of Immunologists

Simvastatin Augments Lipopolysaccharide-Induced Proinflammatory Responses in Macrophages by Differential Regulation of the c-Fos and c-Jun Transcription Factors1

Makoto Matsumoto, Derek Einhaus, Elizabeth S. Gold and Alan Aderem2

Institute for Systems Biology, Seattle, WA 98103

The 3-hydroxyl-3-methylglutaryl-coenzyme A reductase inhibitors, or statins, are a widely used class of drugs for cholesterol reduction. The reduction in mortality and morbidity in statin-treated patients is incompletely explained by their effects on cholesterol, and an anti-inflammatory role for the drug has been proposed. We report in this work that, unexpectedly, simvastatin enhances LPS-induced IL-12p40 production by murine macrophages, and that it does so by activating the IL-12p40 promoter. Mutational analysis and dominant-negative expression studies indicate that both C/EBP and AP-1 transcription factors have a crucial role in promoter activation. This occurs via a c-Fos- and c-Jun-based mechanism; we demonstrate that ectopic expression of c-Jun activates the IL-12p40 promoter, whereas expression of c-Fos inhibits IL-12p40 promoter activity. Simvastatin prevents LPS-induced c-Fos expression, thereby relieving the inhibitory effect of c-Fos on the IL-12p40 promoter. Concomitantly, simvastatin induces the phosphorylation of c-Jun by the c-Jun N-terminal kinase, resulting in c-Jun-dependent activation of the IL-12p40 promoter. This appears to be a general mechanism because simvastatin also augments LPS-dependent activation of the TNF-{alpha} promoter, perhaps because the TNF-{alpha} promoter has C/EBP and AP-1 binding sites in a similar configuration to the IL-12p40 promoter. The fact that simvastatin potently augments LPS-induced IL-12p40 and TNF-{alpha} production has implications for the treatment of bacterial infections in statin-treated patients.




This article has been cited by other articles:


Home page
J. Immunol.Home page
P. R. Kroening, T. W. Barnes, L. Pease, A. Limper, H. Kita, and R. Vassallo
Cigarette Smoke-Induced Oxidative Stress Suppresses Generation of Dendritic Cell IL-12 and IL-23 through ERK-Dependent Pathways
J. Immunol., July 15, 2008; 181(2): 1536 - 1547.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Takahashi, H. Nakamura, M. Seki, Y. Shiraishi, M. Yamamoto, M. Furuuchi, T. Nakajima, S. Tsujimura, T. Shirahata, M. Nakamura, et al.
Reversal of elastase-induced pulmonary emphysema and promotion of alveolar epithelial cell proliferation by simvastatin in mice
Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L882 - L890.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. M. Clarke, A. Lyons, F. O'Connell, B. F. Deighan, C. E. Barry, N. G. Anyakoha, A. Nicolaou, and M. A. Lynch
A Pivotal Role for Interleukin-4 in Atorvastatin-associated Neuroprotection in Rat Brain
J. Biol. Chem., January 25, 2008; 283(4): 1808 - 1817.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. J. Lee, H. Qin, and E. N. Benveniste
Simvastatin inhibits IFN-{gamma}-induced CD40 gene expression by suppressing STAT-1{alpha}
J. Leukoc. Biol., August 1, 2007; 82(2): 436 - 447.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Gianella, E. Nobili, M. Abbate, C. Zoja, P. Gelosa, L. Mussoni, S. Bellosta, M. Canavesi, D. Rottoli, U. Guerrini, et al.
Rosuvastatin Treatment Prevents Progressive Kidney Inflammation and Fibrosis in Stroke-Prone Rats
Am. J. Pathol., April 1, 2007; 170(4): 1165 - 1177.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
M. V. Karamouzis, P. A. Konstantinopoulos, and A. G. Papavassiliou
The Activator Protein-1 Transcription Factor in Respiratory Epithelium Carcinogenesis
Mol. Cancer Res., February 1, 2007; 5(2): 109 - 120.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. Tanaka, C. M. Porter, J. A. Horvath-Arcidiacono, and E. T. Bloom
Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis
Int. Immunol., February 1, 2007; 19(2): 163 - 173.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. D. Patino, J.-G. Kang, S. Matoba, O. Y. Mian, B. R. Gochuico, and P. M. Hwang
Atherosclerotic Plaque Macrophage Transcriptional Regulators Are Expressed in Blood and Modulated by Tristetraprolin
Circ. Res., May 26, 2006; 98(10): 1282 - 1289.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
N. Ray, M. Kuwahara, Y. Takada, K. Maruyama, T. Kawaguchi, H. Tsubone, H. Ishikawa, and K. Matsuo
c-Fos suppresses systemic inflammatory response to endotoxin
Int. Immunol., May 1, 2006; 18(5): 671 - 677.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. R. Coward, A. Marei, A. Yang, M. M. Vasa-Nicotera, and S. C. Chow
Statin-Induced Proinflammatory Response in Mitogen-Activated Peripheral Blood Mononuclear Cells through the Activation of Caspase-1 and IL-18 Secretion in Monocytes
J. Immunol., May 1, 2006; 176(9): 5284 - 5292.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. G. Kay, R. Z. Murray, J. K. Pagan, and J. L. Stow
Cytokine Secretion via Cholesterol-rich Lipid Raft-associated SNAREs at the Phagocytic Cup
J. Biol. Chem., April 28, 2006; 281(17): 11949 - 11954.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Yilmaz, C. Reiss, A. Weng, I. Cicha, C. Stumpf, A. Steinkasserer, W. G. Daniel, and C. D. Garlichs
Differential effects of statins on relevant functions of human monocyte-derived dendritic cells
J. Leukoc. Biol., March 1, 2006; 79(3): 529 - 538.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. F. Tomczak, M. Gadjeva, Y. Y. Wang, K. Brown, I. Maroulakou, P. N. Tsichlis, S. E. Erdman, J. G. Fox, and B. H. Horwitz
Defective Activation of ERK in Macrophages Lacking the p50/p105 Subunit of NF-{kappa}B Is Responsible for Elevated Expression of IL-12 p40 Observed after Challenge with Helicobacter hepaticus
J. Immunol., January 15, 2006; 176(2): 1244 - 1251.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Sekine, T. Yumioka, T. Yamamoto, R. Muromoto, S. Imoto, K. Sugiyma, K. Oritani, K. Shimoda, M. Minoguchi, S. Akira, et al.
Modulation of TLR4 Signaling by a Novel Adaptor Protein Signal-Transducing Adaptor Protein-2 in Macrophages
J. Immunol., January 1, 2006; 176(1): 380 - 389.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Murthy, H. Tong, and R. J. Hohl
Regulation of Fatty Acid Synthesis by Farnesyl Pyrophosphate
J. Biol. Chem., December 23, 2005; 280(51): 41793 - 41804.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Hirotani, P. Y. Lee, H. Kuwata, M. Yamamoto, M. Matsumoto, I. Kawase, S. Akira, and K. Takeda
The Nuclear I{kappa}B Protein I{kappa}BNS Selectively Inhibits Lipopolysaccharide-Induced IL-6 Production in Macrophages of the Colonic Lamina Propria
J. Immunol., March 15, 2005; 174(6): 3650 - 3657.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. B. Fessler, S. K. Young, S. Jeyaseelan, J. G. Lieber, P. G. Arndt, J. A. Nick, and G. S. Worthen
A Role for Hydroxy-Methylglutaryl Coenzyme A Reductase in Pulmonary Inflammation and Host Defense
Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 606 - 615.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Sironi, E. Gianazza, P. Gelosa, U. Guerrini, E. Nobili, A. Gianella, B. Cremonesi, R. Paoletti, and E. Tremoli
Rosuvastatin, but not Simvastatin, Provides End-Organ Protection in Stroke-Prone Rats by Antiinflammatory Effects
Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 598 - 603.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.